PortfoliosLab logoPortfoliosLab logo
Verastem, Inc. (VSTM)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US92337C1045
CUSIP
92337C104
IPO Date
Jan 27, 2012

Highlights

EPS (TTM)
-$3.28
Total Revenue (TTM)
$13.38M
Gross Profit (TTM)
$11.26M
EBITDA (TTM)
-$238.93M
Year Range
$4.01 - $11.25
Target Price
$15.00
ROA (TTM)
-97.83%
ROE (TTM)
-421.54%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Verastem, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Verastem, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Verastem, Inc. (VSTM) has returned -31.35% so far this year and -12.11% over the past 12 months. Over the last ten years, VSTM has returned -11.97% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.


Verastem, Inc.

1D
9.28%
1M
-7.34%
YTD
-31.35%
6M
-39.98%
1Y
-12.11%
3Y*
2.08%
5Y*
-30.06%
10Y*
-11.97%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jan 27, 2012, VSTM's average daily return is +0.07%, while the average monthly return is +1.22%. At this rate, your investment would double in approximately 4.8 years.

Historically, 43% of months were positive and 57% were negative. The best month was May 2023 with a return of +161.1%, while the worst month was Sep 2015 at -70.6%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 8 months.

On a daily basis, VSTM closed higher 45% of trading days. The best single day was May 26, 2023 with a return of +125.6%, while the worst single day was Sep 28, 2015 at -67.4%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-20.98%-6.23%-7.34%-31.35%
202517.60%-7.98%7.77%24.21%0.40%-44.81%48.67%49.92%-4.54%7.02%12.59%-27.44%49.32%
202444.35%6.04%-5.30%-15.42%-60.32%-24.75%-12.75%-3.85%19.60%25.75%42.02%-3.18%-36.49%
202360.72%-19.66%-20.11%-5.92%161.14%-39.22%48.66%-11.75%-16.70%-22.76%9.71%18.14%68.53%
2022-25.37%-21.57%17.50%0.71%-9.86%-9.37%-7.76%8.41%-26.72%-50.59%9.52%-12.50%-80.37%
2021-8.45%20.51%5.11%24.29%26.06%5.17%-20.64%-17.96%16.23%-15.58%2.69%-23.22%-3.76%

Benchmark Metrics

Verastem, Inc. has an annualized alpha of -0.46%, beta of 1.46, and R² of 0.07 versus S&P 500 Index. Calculated based on daily prices since January 30, 2012.

  • This stock participated in 185.28% of S&P 500 Index downside but only 37.05% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.07 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-0.46%
Beta
1.46
0.07
Upside Capture
37.05%
Downside Capture
185.28%

Return for Risk

Risk / Return Rank

VSTM ranks 35 for risk / return — below 35% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


VSTM Risk / Return Rank: 3535
Overall Rank
VSTM Sharpe Ratio Rank: 3434
Sharpe Ratio Rank
VSTM Sortino Ratio Rank: 3939
Sortino Ratio Rank
VSTM Omega Ratio Rank: 3838
Omega Ratio Rank
VSTM Calmar Ratio Rank: 3333
Calmar Ratio Rank
VSTM Martin Ratio Rank: 3333
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Verastem, Inc. (VSTM) and compare them to a chosen benchmark (S&P 500 Index).


VSTMBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.14

0.90

-1.04

Sortino ratio

Return per unit of downside risk

0.41

1.39

-0.97

Omega ratio

Gain probability vs. loss probability

1.05

1.21

-0.16

Calmar ratio

Return relative to maximum drawdown

-0.26

1.40

-1.66

Martin ratio

Return relative to average drawdown

-0.49

6.61

-7.10

Explore VSTM risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Verastem, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Verastem, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Verastem, Inc. was 98.96%, occurring on Aug 5, 2024. The portfolio has not yet recovered.

The current Verastem, Inc. drawdown is 97.49%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.96%Jul 11, 20132786Aug 5, 2024
-46.13%Mar 16, 2012175Nov 26, 2012141Jun 19, 2013316
-7.52%Mar 5, 20124Mar 8, 20125Mar 15, 20129
-6.22%Feb 17, 20125Feb 24, 20122Feb 28, 20127
-4.56%Jan 31, 20128Feb 9, 20125Feb 16, 201213

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Verastem, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Verastem, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for VSTM relative to other companies in the Biotechnology industry. Currently, VSTM has a P/S ratio of 29.2. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items